ASTH (Astrana Health) Piotroski F-Score: 4 (As of Jun. 26, 2026) — 20% Below Median


ASTH Astrana Health Inc ASTH
87 GF Score
Price $43.48
GF Value $82.34
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health Piotroski F-Score?

Astrana Health ASTH +2.98% 87 Piotroski F-Score is 4 as of Jun. 26, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 652 Healthcare Providers & Services companies, Astrana Health ranks worse than 67.33% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Astrana Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Astrana Health's Piotroski F-Score or its related term are showing as below:

ASTH' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 4

During the past 13 years, the highest Piotroski F-Score of Astrana Health was 8. The lowest was 2. And the median was 5.

Astrana Health  (NAS:ASTH) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Astrana Health Piotroski F-Score Related Terms


Astrana Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Astrana Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Piotroski F-Score Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 5.00 5.00 4.00 4.00

Astrana Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 5.00 4.00 4.00 4.00

ASTH vs MD, SGRY, ADUS: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Astrana Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astrana Health Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Astrana Health's Piotroski F-Score falls into.


ASTH
87GF Score
Astrana Health Inc ASTH
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 9.423 + 0.373 + 5.999 + 14.436 = $30 Mil.
Cash Flow from Operations was 90.9 + 9.956 + -2.886 + 68.056 = $166 Mil.
Revenue was 654.808 + 956.048 + 950.526 + 965.1 = $3,526 Mil.
Gross Profit was 77.969 + 97.192 + 95.043 + 105.744 = $376 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(1331.256 + 1442.35 + 2237.186 + 2218.661 + 2358.827) / 5 = $1917.656 Mil.
Total Assets at the begining of this year (Mar25) was $1,331 Mil.
Long-Term Debt & Capital Lease Obligation was $1,010 Mil.
Total Current Assets was $1,004 Mil.
Total Current Liabilities was $745 Mil.
Net Income was 19.171 + 16.094 + -6.951 + 6.692 = $35 Mil.

Revenue was 486.265 + 478.71 + 665.209 + 620.39 = $2,251 Mil.
Gross Profit was 73.46 + 73.492 + 50.479 + 71.329 = $269 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(1226.277 + 1252.471 + 1285.376 + 1354.894 + 1331.256) / 5 = $1290.0548 Mil.
Total Assets at the begining of last year (Mar24) was $1,226 Mil.
Long-Term Debt & Capital Lease Obligation was $433 Mil.
Total Current Assets was $613 Mil.
Total Current Liabilities was $361 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Astrana Health's current Net Income (TTM) was 30. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Astrana Health's current Cash Flow from Operations (TTM) was 166. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=30.231/1331.256
=0.02270863

ROA (Last Year)=Net Income/Total Assets (Mar24)
=35.006/1226.277
=0.02854657

Astrana Health's return on assets of this year was 0.02270863. Astrana Health's return on assets of last year was 0.02854657. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Astrana Health's current Net Income (TTM) was 30. Astrana Health's current Cash Flow from Operations (TTM) was 166. ==> 166 > 30 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=1009.77/1917.656
=0.52656472

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=433.4/1290.0548
=0.33595472

Astrana Health's gearing of this year was 0.52656472. Astrana Health's gearing of last year was 0.33595472. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1004.1/745.369
=1.347118

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=613.27/361.268
=1.69754863

Astrana Health's current ratio of this year was 1.347118. Astrana Health's current ratio of last year was 1.69754863. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Astrana Health's number of shares in issue this year was 49.054. Astrana Health's number of shares in issue last year was 48.851. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=375.948/3526.482
=0.10660709

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=268.76/2250.574
=0.11941842

Astrana Health's gross margin of this year was 0.10660709. Astrana Health's gross margin of last year was 0.11941842. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=3526.482/1331.256
=2.64898862

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=2250.574/1226.277
=1.83529007

Astrana Health's asset turnover of this year was 2.64898862. Astrana Health's asset turnover of last year was 1.83529007. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+0+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Astrana Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Astrana Health (ASTH) has a Piotroski F-Score of 4 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Astrana Health and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, Astrana Health's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Astrana Health ranks #439 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 67.3%.
Is Astrana Health's Piotroski F-Score too high?
Astrana Health's current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Astrana Health's value of 4 is 20% below this industry median. Based on the distribution chart, Astrana Health ranks #439 out of 652 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Piotroski F-Score compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #439 out of 652 companies for Piotroski F-Score. This places Astrana Health in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Astrana Health's value of 4 is 20% below this benchmark. Historically, Astrana Health's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Astrana Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $43.48 — trading 47.2% below its estimated fair value. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 20% below the Healthcare Providers & Services industry median of 5.00. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Astrana Health (ASTH), the current Piotroski F-Score is 4 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $43.48 is trading 47.2% below its estimated GF Value™ of $82.34. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • Piotroski F-Score: 4 (20% below median its 10-year median of 5.00)
  • GF Value™: $82.34 vs. price of $43.48 (47.2% below fair value)
  • GF Score™: 87/100 with 8 warning signs
  • Industry Position: 20% below the Healthcare Providers & Services median (#439 of 652)

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.48
Price
$82.34
GF Value